Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Revolutionizing Skin Health with our Advanced Engineered Biotherapeutics

Objective

We have developed a ground-breaking patented technology that uses genetically engineered skin bacteria (C. acnes) to deliver biotherapeutics directly to the skin, offering safe, effective and long-lasting treatment for skin conditions such as acne. Our modified microbes continuously produce and secrete therapeutic molecules in the hair follicle, addressing the problems associated with invasive procedures and the poor transdermal penetration of traditional topical treatments.
Preclinical results from our previous EIC Transition project SKINDEV (coordinated by UPF), have demonstrated significant efficacy in reducing sebum and inflammation in vitro. Additionally, further studies have shown successful engraftment and safety in mouse models. The SkinEngineering project will advance our technology from proof-of-concept (TRL3) to preclinical and regulatory validation (TRL5), bridging the gap between promising research outcomes and the stage where we are ready to enter into commercial agreements with potential partners.
SkinEngineering will help us further refine our platform, complete preclinical studies and address regulatory and manufacturing aspects. We will also focus on ensuring the safety of our engineered bacteria, including robust biocontainment strategies. We have preliminarily validated the market fit of this effective and non-invasive therapy without adverse effects, confirming that it meets the needs of clinicians and patients in the 14 billion acne market. Our biotherapeutic also reduces the need for antimicrobial-based treatments, helping combat antimicrobial resistance, a key public health issue.
Our commercialization pathway involves launching a spin-off, Synflora, with SkinEngineering refining our business model and go-to-market strategy. Successful project outcomes will capture the attention of key stakeholders, e.g. investors, pharma/cosmetic companies and end users, boosting our companys awareness and enhancing its investment readiness.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) HORIZON-EIC-2024-TRANSITION-01

See all projects funded under this call

Coordinator

UNIVERSIDAD POMPEU FABRA
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 2 499 999,00
Address
PLACA DE LA MERCE, 10-12
08002 Barcelona
Spain

See on map

Region
Este Cataluña Barcelona
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data
My booklet 0 0